Wang Xin, Chang Xiaona, Wang Qiu, Ding Xiaoyu, Wang Jiaxuan, Cui Ruixiang, Wang Guang, Liu Jia
Heart Center and Beijing Key Laboratory of Hypertension Research, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Int J Endocrinol. 2024 Oct 21;2024:7144798. doi: 10.1155/2024/7144798. eCollection 2024.
Adropin is a unique hormone, which controls metabolism and energy homeostasis. Hyperthyroidism is a disease with a high metabolic rate that affects both glucose and lipid metabolism. We aimed to investigate the change of adropin levels and the association between adropin levels and clinical parameters in patients with hyperthyroidism. This cross-sectional study comprised 90 newly diagnosed patients with hyperthyroidism and 90 age- and gender-matched healthy controls. Circulating adropin levels and thyroid hormone levels were evaluated in each participant. Compared with the healthy controls, the hyperthyroid patients had significantly higher levels of serum adropin ( < 0.001). In addition, adropin levels were positively correlated with free triiodothyronine (FT3) and free thyroxine (FT4), whereas they were negatively correlated with thyroid-stimulating hormone (TSH). A multivariate linear regression analysis showed that serum adropin concentrations were independently correlated with FT3 and TSH after adjustment for age, gender, and other confounding factors (FT3: = 0.231, < 0.05; TSH: = -0.301, < 0.05). Patients with hyperthyroidism had elevated serum adropin levels. And the serum adropin concentrations were independently correlated with the FT3 and TSH levels.
内脂素是一种独特的激素,它控制新陈代谢和能量稳态。甲状腺功能亢进症是一种代谢率高的疾病,会影响葡萄糖和脂质代谢。我们旨在研究甲状腺功能亢进症患者内脂素水平的变化以及内脂素水平与临床参数之间的关联。这项横断面研究包括90例新诊断的甲状腺功能亢进症患者和90例年龄及性别匹配的健康对照者。对每位参与者的循环内脂素水平和甲状腺激素水平进行了评估。与健康对照者相比,甲状腺功能亢进症患者的血清内脂素水平显著更高(<0.001)。此外,内脂素水平与游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)呈正相关,而与促甲状腺激素(TSH)呈负相关。多因素线性回归分析显示,在调整年龄、性别和其他混杂因素后,血清内脂素浓度与FT3和TSH独立相关(FT3:=0.231,<0.05;TSH:= -0.301,<0.05)。甲状腺功能亢进症患者的血清内脂素水平升高。并且血清内脂素浓度与FT3和TSH水平独立相关。